Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Amgen Inc.
AMGNHealth technology
$169B
Market Cap
Shariah Analysis
Failed
Business
Cash
Liabilities
Based on AAOIFI screening standards, Amgen Inc. appears to be Failed.
Business Activity
FYE 2024
Non-Permissible Income (<5%)1.50%
Non-Permissible
$510
Total Income
$33.9K
Revenue Breakdown
Product sales
$32K
Other revenues
$1.4K
Interest income
Non-Operating
$510
Non-Compliant: $510
Equity in (income) loss of equity method investments
Non-Operating
$10
Financial Screening
FYE 2024
Cash (<30%)8.83%
Non-Shariah Cash Items
Cash And Cash Equivalents$12B
Liabilities (<30%)44.34%
Non-Shariah Liabilities
Long Term Debt$56.5B
Current Debt$3.5B
Market Data
Exchange
NASDAQ
CurrencyUSD
CountryUnited States
Last Updated2025-12-26
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.